Drug recalls, 2026-W02

FDA drug recalls, January 5 to 11, 2026

FDA posted 5 drug recalls the week of January 5, 2026: 4 Class II and 1 Class III. Novo Nordisk Inc. has the most, with 2.

License: openFDA publishes this file under CC0 1.0.

FDA sorts recalls by risk. Class I: using the product could cause serious health problems or death. Class II: it could cause temporary or reversible health problems. Class III: it is unlikely to cause health problems.

For pharmacies and practices

Get this every Monday

Rivvi pulls the FDA drug recalls posted in the last 7 days and sends you the list each Monday morning. Add the drugs you stock or prescribe and it flags any that match.

Watch recalls in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams, with the weekly watch turned on.

Recalls posted January 5 to 11, 2026

Class II · Posted January 7, 2026 · Started December 30, 2025 · Ongoing

ondansetron

Product
Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13
Firm
Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ
Reason
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Lots
Lot #: 19251311, Exp Date April 2027
Quantity
96,948 packs
Distribution
Nationwide within the United States
RxNorm
ondansetron (RxCUI 104894, 198052, 312086, 312087)
Recall number
D-0246-2026

Class III · Posted January 7, 2026 · Started December 19, 2025 · Ongoing

trazodone hydrochloride

Product
traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10
Firm
Zydus Pharmaceuticals (USA) Inc, Pennington, NJ
Reason
Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
Lots
Lot # EA00237A, Exp Date: 04/30/2027
Quantity
2,136 1000-count bottles
Distribution
Nationwide in the USA
RxNorm
trazodone hydrochloride (RxCUI 856364, 856369, 856373, 856377)
Recall number
D-0247-2026

Class II · Posted January 7, 2026 · Started December 19, 2025 · Ongoing

Wegovy (semaglutide) Injection

Product
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
Firm
Novo Nordisk Inc., Plainsboro, NJ
Reason
Presence of Particulate Matter: Hair was found in a prefilled syringe
Lots
Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027
Distribution
Nationwide within the United States.
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0245-2026

Class II · Posted January 7, 2026 · Started December 19, 2025 · Ongoing

Wegovy (semaglutide) Injection

Product
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
Firm
Novo Nordisk Inc., Plainsboro, NJ
Reason
Presence of Particulate Matter: Hair was found in a prefilled syringe
Lots
Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026
Distribution
Nationwide within the United States.
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0244-2026

Class II · Posted January 7, 2026 · Started December 17, 2025 · Ongoing

chlorhexidine gluconate and isopropyl alcohol

Product
BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG), 2% w/v and Isopropyl alcohol (IPA), 70% v/v), 5.25 mL Applicator, CareFusion 213, LLC, El Paso, TX 79912, NDC 54365-401-29
Firm
CareFusion 213, LLC, El Paso, TX
Reason
Lack of Assurance of Sterlity
Lots
Lot #: 5086623, Exp. Date 03/31/2028
Quantity
106,400 units
Distribution
Nationwide within the United States
RxNorm
chlorhexidine gluconate and isopropyl alcohol (RxCUI 1918214)
Recall number
D-0243-2026

Source: openFDA drug enforcement reports, as of October 14, 2026. Publisher page

About this data

Each row is one FDA drug enforcement report: one product from one firm. A week here is Monday to Sunday, keyed on the date FDA listed the recall in its weekly Enforcement Report. The date the firm started the recall is shown on each row and is often weeks earlier.

Class I means use of the product could cause serious health problems or death. Class II means it could cause temporary or reversible health problems. Class III means it is unlikely to cause health problems. RxNorm names and RxCUIs come from openFDA's match of the product to its drug label. Compounded products often have no match.

This page lists public records. It is not medical advice. Check the FDA record before acting on a recall.

Source: openFDA drug enforcement reports, as of October 14, 2026. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.

Get started for freeSee pricing